Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1243 entries
Sorted by: Best Match Show Resources per page
Sex, race, and smoking impact olanzapine exposure

race as an overall term & individual races (e.g. American Indian

Bigos KL, Pollock BG, Coley KC.
GSID: A8PQWl66GvkJ
KL Bigos, BG Pollock, KC Coley… - The Journal of …, 2008 - Wiley Online Library

… the most effective antipsychotic studied in terms of the rates of discontinuation … American Indian, Asian alone, black/African American, Native Hawaiian, white alone, and 2 or more races…

Cite
Bigos, K. L., Pollock, B. G., Coley, K. C., Miller, D. D., Marder, S. R., Aravagiri, M., ... & Bies, R. R. (2008). Sex, race, and smoking impact olanzapine exposure. The Journal of Clinical Pharmacology, 48(2), 157-165.
Bigos, Kristin L., et al. "Sex, race, and smoking impact olanzapine exposure." The Journal of Clinical Pharmacology 48.2 (2008): 157-165.
Copy Download .nbib Format: MLA
Case of Secondary Tics Associated With Olanzapine in an Adult.

Frontiers in psychiatry

Mills EW, Shaffer LS, Goes FS, Sawa A, Nucifora FC.
PMID: 28861008
Front Psychiatry. 2017 Aug 15;8:150. doi: 10.3389/fpsyt.2017.00150. eCollection 2017.

Atypical antipsychotic medications, such as risperidone, aripiprazole, and olanzapine, have utility in treating motor tics, particularly in Tourette syndrome. In rare cases, atypical antipsychotic medications have been associated with adult-onset motor tics. Such adverse drug reactions have been documented...

Cite
Mills EW, Shaffer LS, Goes FS, et al. Case of Secondary Tics Associated With Olanzapine in an Adult. Front Psychiatry. 2017;8:150doi: 10.3389/fpsyt.2017.00150.
Mills, E. W., Shaffer, L. S., Goes, F. S., Sawa, A., & Nucifora, F. C. (2017). Case of Secondary Tics Associated With Olanzapine in an Adult. Frontiers in psychiatry, 8150. https://doi.org/10.3389/fpsyt.2017.00150
Mills, Eric W, et al. "Case of Secondary Tics Associated With Olanzapine in an Adult." Frontiers in psychiatry vol. 8 (2017): 150. doi: https://doi.org/10.3389/fpsyt.2017.00150
Mills EW, Shaffer LS, Goes FS, Sawa A, Nucifora FC. Case of Secondary Tics Associated With Olanzapine in an Adult. Front Psychiatry. 2017 Aug 15;8:150. doi: 10.3389/fpsyt.2017.00150. eCollection 2017. PMID: 28861008; PMCID: PMC5559475.
Copy Download .nbib Format: NLM
Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials.

BJPsych open

Zhao YJ, Lin L, Teng M, Khoo AL, Soh LB, Furukawa TA, Baldessarini RJ, Lim BP, Sim K.
PMID: 27703755
BJPsych Open. 2016 Feb 05;2(1):59-66. doi: 10.1192/bjpo.bp.115.002576. eCollection 2016 Jan.

BACKGROUND: For treatment of patients diagnosed with schizophrenia, comparative long-term effectiveness of antipsychotic drugs to reduce relapses when minimising adverse effects is of clinical interest, hence prompting this review.AIMS: To evaluate the comparative long-term effectiveness of antipsychotic drugs.METHOD: We...

Cite
Zhao YJ, Lin L, Teng M, et al. Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials. BJPsych Open. 2016;2(1):59-66doi: 10.1192/bjpo.bp.115.002576.
Zhao, Y. J., Lin, L., Teng, M., Khoo, A. L., Soh, L. B., Furukawa, T. A., Baldessarini, R. J., Lim, B. P., & Sim, K. (2016). Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials. BJPsych open, 2(1), 59-66. https://doi.org/10.1192/bjpo.bp.115.002576
Zhao, Ying Jiao, et al. "Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials." BJPsych open vol. 2,1 (2016): 59-66. doi: https://doi.org/10.1192/bjpo.bp.115.002576
Zhao YJ, Lin L, Teng M, Khoo AL, Soh LB, Furukawa TA, Baldessarini RJ, Lim BP, Sim K. Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials. BJPsych Open. 2016 Feb 05;2(1):59-66. doi: 10.1192/bjpo.bp.115.002576. eCollection 2016 Jan. PMID: 27703755; PMCID: PMC4995551.
Copy Download .nbib Format: NLM
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life.

Neuropsychiatric disease and treatment

Montemagni C, Frieri T, Rocca P.
PMID: 27143893
Neuropsychiatr Dis Treat. 2016 Apr 19;12:917-29. doi: 10.2147/NDT.S88632. eCollection 2016.

Long-acting injectable antipsychotics (LAIs) were developed to make treatment easier, improve adherence, and/or signal the clinician when nonadherence occurs. Second-generation antipsychotic LAIs (SGA-LAIs) combine the advantages of SGA with a long-acting formulation. The purpose of this review is to...

Cite
Montemagni C, Frieri T, Rocca P. Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life. Neuropsychiatr Dis Treat. 2016;12:917-29doi: 10.2147/NDT.S88632.
Montemagni, C., Frieri, T., & Rocca, P. (2016). Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life. Neuropsychiatric disease and treatment, 12917-29. https://doi.org/10.2147/NDT.S88632
Montemagni, Cristiana, et al. "Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life." Neuropsychiatric disease and treatment vol. 12 (2016): 917-29. doi: https://doi.org/10.2147/NDT.S88632
Montemagni C, Frieri T, Rocca P. Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life. Neuropsychiatr Dis Treat. 2016 Apr 19;12:917-29. doi: 10.2147/NDT.S88632. eCollection 2016. PMID: 27143893; PMCID: PMC4844443.
Copy Download .nbib Format: NLM
Psychiatric disturbances as a first clinical symptom of Wilson's disease - case report.

Psychiatria polska

Litwin T, Dzieżyc K, Karliński M, Szafrański T, Członkowska A.
PMID: 27288679
Psychiatr Pol. 2016;50(2):337-344. doi: 10.12740/PP/45218.

OBJECTIVES: Wilson's disease (WD) is an inherited disorder of copper metabolism with wide spectrum of clinical symptoms, mainly hepatic or neurological. Psychiatric disorders occur less frequently and are not pathognomonic for WD. However, in almost 20% of cases they...

Cite
Litwin T, Dzieżyc K, Karliński M, et al. Zaburzenia psychiatryczne jako pierwszy objaw choroby Wilsona - opis przypadku. Psychiatric disturbances as a first clinical symptom of Wilson's disease - case report. Psychiatr Pol. 2016;50(2):337-344doi: 10.12740/PP/45218.
Litwin, T., Dzieżyc, K., Karliński, M., Szafrański, T., & Członkowska, A. (2016). Zaburzenia psychiatryczne jako pierwszy objaw choroby Wilsona - opis przypadku. Psychiatric disturbances as a first clinical symptom of Wilson's disease - case report. Psychiatria polska, 50(2), 337-344. https://doi.org/10.12740/PP/45218
Litwin, Tomasz, et al. "Zaburzenia psychiatryczne jako pierwszy objaw choroby Wilsona - opis przypadku." Psychiatric disturbances as a first clinical symptom of Wilson's disease - case report. Psychiatria polska vol. 50,2 (2016): 337-344. doi: https://doi.org/10.12740/PP/45218
Litwin T, Dzieżyc K, Karliński M, Szafrański T, Członkowska A. Zaburzenia psychiatryczne jako pierwszy objaw choroby Wilsona - opis przypadku. Psychiatric disturbances as a first clinical symptom of Wilson's disease - case report. Psychiatr Pol. 2016;50(2):337-344. doi: 10.12740/PP/45218. Polish. PMID: 27288679.
Copy Download .nbib Format: NLM
Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study.

Neuropsychiatric disease and treatment

Wani RA, Dar MA, Chandel RK, Rather YH, Haq I, Hussain A, Malla AA.
PMID: 25792838
Neuropsychiatr Dis Treat. 2015 Mar 13;11:685-93. doi: 10.2147/NDT.S80925. eCollection 2015.

BACKGROUND: Patients with schizophrenia suffer high rates of metabolic derangements on some antipsychotic medications that predispose them to cardiovascular diseases. Keeping this fact in mind, we planned this open-label study to see the effect on various metabolic parameters after...

Cite
Wani RA, Dar MA, Chandel RK, et al. Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study. Neuropsychiatr Dis Treat. 2015;11:685-93doi: 10.2147/NDT.S80925.
Wani, R. A., Dar, M. A., Chandel, R. K., Rather, Y. H., Haq, I., Hussain, A., & Malla, A. A. (2015). Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study. Neuropsychiatric disease and treatment, 11685-93. https://doi.org/10.2147/NDT.S80925
Wani, Rayees Ahmad, et al. "Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study." Neuropsychiatric disease and treatment vol. 11 (2015): 685-93. doi: https://doi.org/10.2147/NDT.S80925
Wani RA, Dar MA, Chandel RK, Rather YH, Haq I, Hussain A, Malla AA. Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study. Neuropsychiatr Dis Treat. 2015 Mar 13;11:685-93. doi: 10.2147/NDT.S80925. eCollection 2015. PMID: 25792838; PMCID: PMC4364593.
Copy Download .nbib Format: NLM
[Not Available].

Therapie

Chebane L, Tavassoli N, Bagheri H, Jean-LouisMontastruc.
PMID: 27393246
Therapie. 2010 Sep-Oct;65(5):447-58. doi: 10.2515/therapie/2010051.

OBJECTIVE: To analyse drugs inducing hyperglycemia by using data reported to the French spontaneous reporting system and recorded in the French PharmacoVigilance Database (FPVD).METHODS: All cases with a report of hyperglycemia and/or diabetes in the French database between 1985...

Cite
Chebane L, Tavassoli N, Bagheri H, et al. Hyperglycémies d'origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV). [Not Available]. Therapie. 2010;65(5):447-58doi: 10.2515/therapie/2010051.
Chebane, L., Tavassoli, N., Bagheri, H., Jean-LouisMontastruc. (2010). Hyperglycémies d'origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV). [Not Available]. Therapie, 65(5), 447-58. https://doi.org/10.2515/therapie/2010051
Chebane, Leila, et al. "Hyperglycémies d'origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV)." [Not Available]. Therapie vol. 65,5 (2010): 447-58. doi: https://doi.org/10.2515/therapie/2010051
Chebane L, Tavassoli N, Bagheri H, Jean-LouisMontastruc. Hyperglycémies d'origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV). [Not Available]. Therapie. 2010 Sep-Oct;65(5):447-58. doi: 10.2515/therapie/2010051. French. PMID: 27393246.
Copy Download .nbib Format: NLM
Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case register.

NPJ schizophrenia

Cardinal RN, Savulich G, Mann LM, Fernández-Egea E.
PMID: 27336041
NPJ Schizophr. 2015 Oct 21;1:15035. doi: 10.1038/npjschz.2015.35. eCollection 2015.

BACKGROUND: The impact of psychotropic drug choice upon admissions for schizophrenia is not well understood.AIMS: To examine the association between antipsychotic/antidepressant use and time in hospital for patients with schizophrenia.METHODS: We conducted an observational study, using 8 years' admission...

Cite
Cardinal RN, Savulich G, Mann LM, et al. Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case register. NPJ Schizophr. 2015;1:15035doi: 10.1038/npjschz.2015.35.
Cardinal, R. N., Savulich, G., Mann, L. M., & Fernández-Egea, E. (2015). Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case register. NPJ schizophrenia, 115035. https://doi.org/10.1038/npjschz.2015.35
Cardinal, Rudolf N, et al. "Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case register." NPJ schizophrenia vol. 1 (2015): 15035. doi: https://doi.org/10.1038/npjschz.2015.35
Cardinal RN, Savulich G, Mann LM, Fernández-Egea E. Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case register. NPJ Schizophr. 2015 Oct 21;1:15035. doi: 10.1038/npjschz.2015.35. eCollection 2015. PMID: 27336041; PMCID: PMC4849458.
Copy Download .nbib Format: NLM
The effect of folate supplementation and genotype on cardiovascular and epigenetic measures in schizophrenia subjects.

NPJ schizophrenia

Ellingrod VL, Grove TB, Burghardt KJ, Taylor SF, Dalack G.
PMID: 27336047
NPJ Schizophr. 2015 Nov 11;1:15046. doi: 10.1038/npjschz.2015.46. eCollection 2015.

BACKGROUND: Metabolic syndrome may be related to folate's pharmacogenetically regulated metabolism and atypical antipsychotic (AAP) exposure.AIMS: We examined folate supplementation on metabolic measures, endothelial functioning (Reactive Hyperemia Index (RHI)), and global methylation in AAP-treated schizophrenia subjects meeting NCEP-ATP-III-a metabolic...

Cite
Ellingrod VL, Grove TB, Burghardt KJ, et al. The effect of folate supplementation and genotype on cardiovascular and epigenetic measures in schizophrenia subjects. NPJ Schizophr. 2015;1:15046doi: 10.1038/npjschz.2015.46.
Ellingrod, V. L., Grove, T. B., Burghardt, K. J., Taylor, S. F., & Dalack, G. (2015). The effect of folate supplementation and genotype on cardiovascular and epigenetic measures in schizophrenia subjects. NPJ schizophrenia, 115046. https://doi.org/10.1038/npjschz.2015.46
Ellingrod, Vicki L, et al. "The effect of folate supplementation and genotype on cardiovascular and epigenetic measures in schizophrenia subjects." NPJ schizophrenia vol. 1 (2015): 15046. doi: https://doi.org/10.1038/npjschz.2015.46
Ellingrod VL, Grove TB, Burghardt KJ, Taylor SF, Dalack G. The effect of folate supplementation and genotype on cardiovascular and epigenetic measures in schizophrenia subjects. NPJ Schizophr. 2015 Nov 11;1:15046. doi: 10.1038/npjschz.2015.46. eCollection 2015. PMID: 27336047; PMCID: PMC4849464.
Copy Download .nbib Format: NLM
New therapies for antiemetic prophylaxis for chemotherapy.

The Journal of community and supportive oncology

Davis MP.
PMID: 26870838
J Community Support Oncol. 2016 Jan;14(1):11-20. doi: 10.12788/jcso.0206.

A number of new advances have occurred over the past 2 years in the management of chemotherapy-related nausea and vomiting (CINV). A new neurokinin-1 receptor antagonist (NK1RA), netupitant, has been combined with palonosetron in a single oral tablet for...

Cite
Davis MP. New therapies for antiemetic prophylaxis for chemotherapy. J Community Support Oncol. 2016;14(1):11-20doi: 10.12788/jcso.0206.
Davis, M. P. (2016). New therapies for antiemetic prophylaxis for chemotherapy. The Journal of community and supportive oncology, 14(1), 11-20. https://doi.org/10.12788/jcso.0206
Davis, Mellar P. "New therapies for antiemetic prophylaxis for chemotherapy." The Journal of community and supportive oncology vol. 14,1 (2016): 11-20. doi: https://doi.org/10.12788/jcso.0206
Davis MP. New therapies for antiemetic prophylaxis for chemotherapy. J Community Support Oncol. 2016 Jan;14(1):11-20. doi: 10.12788/jcso.0206. PMID: 26870838.
Copy Download .nbib Format: NLM
Self-limiting Atypical Antipsychotics-induced Edema: Clinical Cases and Systematic Review.

Indian journal of psychological medicine

Umar MU, Abdullahi AT.
PMID: 27335511
Indian J Psychol Med. 2016 May-Jun;38(3):182-8. doi: 10.4103/0253-7176.183089.

A number of atypical antipsychotics have been associated with peripheral edema. The exact cause is not known. We report two cases of olanzapine-induced edema and a brief review of atypical antipsychotic-induced edema, possible risk factors, etiology, and clinical features....

Cite
Umar MU, Abdullahi AT. Self-limiting Atypical Antipsychotics-induced Edema: Clinical Cases and Systematic Review. Indian J Psychol Med. 2016;38(3):182-8doi: 10.4103/0253-7176.183089.
Umar, M. U., & Abdullahi, A. T. (2016). Self-limiting Atypical Antipsychotics-induced Edema: Clinical Cases and Systematic Review. Indian journal of psychological medicine, 38(3), 182-8. https://doi.org/10.4103/0253-7176.183089
Umar, Musa Usman, and Abdullahi, Aminu Taura. "Self-limiting Atypical Antipsychotics-induced Edema: Clinical Cases and Systematic Review." Indian journal of psychological medicine vol. 38,3 (2016): 182-8. doi: https://doi.org/10.4103/0253-7176.183089
Umar MU, Abdullahi AT. Self-limiting Atypical Antipsychotics-induced Edema: Clinical Cases and Systematic Review. Indian J Psychol Med. 2016 May-Jun;38(3):182-8. doi: 10.4103/0253-7176.183089. PMID: 27335511; PMCID: PMC4904752.
Copy Download .nbib Format: NLM
Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review.

Neuropsychiatric disease and treatment

Zhang L, Li J, Zhao Y, Su Y, Si T.
PMID: 26811684
Neuropsychiatr Dis Treat. 2016 Jan 11;12:113-31. doi: 10.2147/NDT.S64672. eCollection 2016.

BACKGROUND: Paliperidone (9-hydroxyrisperidone), the major active metabolite of risperidone, has been introduced as a novel atypical antipsychotic agent in many countries. It is available both as an oral extended-release (ER) formulation and as a long-acting injection (paliperidone palmitate, PP),...

Cite
Zhang L, Li J, Zhao Y, et al. Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review. Neuropsychiatr Dis Treat. 2016;12:113-31doi: 10.2147/NDT.S64672.
Zhang, L., Li, J., Zhao, Y., Su, Y., & Si, T. (2016). Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review. Neuropsychiatric disease and treatment, 12113-31. https://doi.org/10.2147/NDT.S64672
Zhang, LiLi, et al. "Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review." Neuropsychiatric disease and treatment vol. 12 (2016): 113-31. doi: https://doi.org/10.2147/NDT.S64672
Zhang L, Li J, Zhao Y, Su Y, Si T. Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review. Neuropsychiatr Dis Treat. 2016 Jan 11;12:113-31. doi: 10.2147/NDT.S64672. eCollection 2016. PMID: 26811684; PMCID: PMC4714741.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1243 entries